This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Click here for Inflectra® (infliximab) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.

Inflammatory bowel disease

​​​​​​​Inflammatory Bowel Disease (IBD) is a term mainly used to describe two long-term conditions: ulcerative colitis (UC) and Crohn's disease (CD).

​​​​​​​The incidence and prevalence of IBD are increasing over time and in virtually every region of the world.1,2

​​​​​​​CD and UC complication rates are high2

Watch the video to hear physicians discuss Study 3.4 at UEGW 2017

Explore more

Study 3.4 (CD and UC)

Read about the landmark Study 3.4 in patients with Crohn’s disease and ulcerative colitis

Learn more

References 
  1. Molodecky NA, et al. Gastroenterology 2012. 142:46-54.
  2. Burisch J, et al. J Crohn’s Colitis 2013. 7:322-37.
PP-IFA-GBR-0402. March 2021

Quick Links

  • Biosimilars

  • Infliximab mechanism of action

  • Support & Resources

Read about dosing and administration of Inflectra in patients with ulcerative colitis. 

Find out more

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No